Glimizest MV 1mg/500mg/0.2mg Tablet
strip of 10.0 tablets.Prescription required
About this product:
| Salt Composition: | Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg) |
| Manufacturer: | Alniche Life Sciences Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Glimizest MV 1mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults. Glimizest MV 1mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Glimizest MV 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
What is Glimizest MV 1mg/500mg/0.2mg Tablet?
Glimizest MV 1mg/500mg/0.2mg Tablet is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medication is used in the treatment of type 2 diabetes mellitus (DM). It helps to improve blood glucose levels in adults when taken with proper diet and exercise. Glimepiride lowers blood glucose levels by increasing insulin release from the pancreas. Metformin works by decreasing glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) blood glucose levels.
What are the possible side effects of Glimizest MV 1mg/500mg/0.2mg Tablet?
Possible side effects include hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Are there any specific conditions in which Glimizest MV 1mg/500mg/0.2mg Tablet should not be taken?
Avoid using this medicine if you are allergic to any of its components or excipients, have severe kidney disease or inflammatory bowel disease. It is also unsuitable for those with metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Glimizest MV 1mg/500mg/0.2mg Tablet?
No, alcohol should not be taken with Glimizest MV 1mg/500mg/0.2mg Tablet because it can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Can the use of Glimizest MV 1mg/500mg/0.2mg Tablet cause hypoglycemia?
Yes, Glimizest MV 1mg/500mg/0.2mg Tablet can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It is more likely if you miss or delay your meals, drink alcohol, over-exercise, or take other antidiabetic medications together with it. Regular monitoring of blood glucose levels is crucial. Always keep glucose tablets, honey or fruit juice with you.
What are the instructions for the storage and disposal of Glimizest MV 1mg/500mg/0.2mg Tablet?
Store this medication in its original packaging, tightly closed. Store it according to the instructions on the label or pack, disposing of unused medicine appropriately. Ensure that pets, children, and other people are not able to access or consume the medicine.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimizest MV 1mg/500mg/0.2mg Tablet is to be taken empty stomach.
- Take it with food to lower your chance of having an upset stomach.
- It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines
- alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief.
- Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
- No common side effects listed.
Alcohol
It is unsafe to consume alcohol with Glimizest MV 1mg/500mg/0.2mg Tablet.
Breastfeed
Glimizest MV 1mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Glimizest MV 1mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby.
